# High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease

> **NCT01531751** · PHASE2 · WITHDRAWN · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia**

## Conditions studied

- Primary Amyloidosis of Light Chain Type

## Interventions

- **DEVICE:** High Cut-off Hemodialysis
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT01531751
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01531751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01531751, "High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01531751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*